Search peptides, terms, sources/
Glossary

Incretin

A hormone released from the gut after eating that helps regulate insulin release and blood sugar. GLP-1 (glucagon-like peptide-1) is the best-known incretin, and several peptides on this site, including semaglutide, tirzepatide, liraglutide and retatrutide, are described as “incretin mimetics” because they are engineered to activate the same receptors as the body’s own incretin hormones, typically with a longer-lasting effect than the natural hormone.

Peptides where this matters

  • Semaglutide

    GLP-1 receptor agonist studied in type 2 diabetes, weight management and cardiovascular outcomes. UK prescription-only medicine; studied in large randomised trials.

    Metabolic and incretinHuman trialsEvidence reviewed
    StrongLicensed UK medicine
  • Tirzepatide

    Dual GIP and GLP-1 receptor agonist studied in type 2 diabetes and weight management. UK prescription-only medicine; studied in large randomised trials.

    Metabolic and incretinHuman trialsEvidence reviewed
    StrongLicensed UK medicine
  • Liraglutide

    Earlier-generation GLP-1 receptor agonist studied in type 2 diabetes and weight management. UK prescription-only medicine; licence status depends on the brand.

    Metabolic and incretinHuman trialsEvidence reviewed
    ModerateLicensed UK medicine
  • RetatrutideLY3437943

    Investigational triple GIP, GLP-1 and glucagon receptor agonist studied for weight management. Not licensed in the UK; studied in a Phase 2 trial.

    Metabolic and incretinHuman trialsEvidence reviewed
    ModerateNot licensed in the UK

All glossary terms

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.